Aids Res Hum Retroviruses

• 

  Publication Venue For

  • Multiplex Analysis of Cytokines and Chemokines in Persons Aging With or Without HIV. 2023
  • Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIV..  38:735-742. 2022
  • Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam..  38:441-450. 2022
  • Understanding Retention in Pre-Exposure Prophylaxis Care in the South: Insights from an Academic HIV Prevention Clinic..  38:306-312. 2022
  • The Mid-Atlantic Centers for AIDS Research Consortium: Promoting HIV Science Through Regional Collaboration..  38:181-187. 2022
  • Skipped Over: Tuning Natural Killer Cells Toward HIV Through Alternative Splicing..  36:969-972. 2020
  • Correlates of Water-Based Lubricant Use Among Men Who Have Sex with Men in Blantyre, Malawi..  35:833-841. 2019
  • Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy..  35:746-754. 2019
  • HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights..  35:598-607. 2019
  • Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques..  35:310-325. 2019
  • Harvard HIV and Aging Workshop: Perspectives and Priorities from Claude D. Pepper Centers and Centers for AIDS Research..  35:999-1012. 2019
  • Racial Differences in Change in Physical Functioning in Older Male Veterans with HIV..  35:1034-1043. 2019
  • Low Levels of Physical Activity Among Older Persons Living with HIV/AIDS Are Associated with Poor Physical Function..  34:929-935. 2018
  • Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use..  34:867-878. 2018
  • Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled Trial..  34:193-205. 2018
  • "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry..  34:67-79. 2018
  • HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania..  33:1107-1113. 2017
  • Beyond Viral Neutralization..  33:760-764. 2017
  • HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies..  33:859-868. 2017
  • Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers..  33:880-888. 2017
  • HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication..  33:690-702. 2017
  • Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico..  33:524-533. 2017
  • Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates..  33:428-431. 2017
  • The Landscape of Targeted Immune Responses in the HIV-1 Vaccine Field..  32:944-946. 2016
  • A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses..  31:1126-1138. 2015
  • HIV Transmission Patterns Among Immigrant Latinos Illuminated by the Integration of Phylogenetic and Migration Data..  31:973-980. 2015
  • Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patients..  29:1365-1369. 2013
  • Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy..  29:1000-1005. 2013
  • Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation..  29:493-500. 2013
  • Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes..  29:511-515. 2013
  • Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons..  29:435-440. 2013
  • Acute HIV-1 infection in the Southeastern United States: a cohort study..  29:121-128. 2013
  • Associations of consistent condom use among men who have sex with men in Abuja, Nigeria..  28:1756-1762. 2012
  • The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120..  28:1444-1457. 2012
  • Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation..  28:789-792. 2012
  • Risks for HIV infection among gay, bisexual, and other men who have sex with men in Moscow and St. Petersburg, Russia..  28:874-879. 2012
  • The role of dynamin in HIV type 1 Env-mediated cell-cell fusion..  27:1013-1017. 2011
  • Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F..  27:889-901. 2011
  • Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China..  27:925-930. 2011
  • Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women..  27:469-486. 2011
  • RecDraw: a software package for the representation of HIV-1 recombinant structures..  26:1317-1321. 2010
  • Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users..  26:855-859. 2010
  • Similar T-cell immune responses induced by group M consensus env immunogens with wild-type or minimum consensus variable regions..  26:577-584. 2010
  • Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production..  26:279-291. 2010
  • HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry..  26:13-24. 2010
  • Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania..  25:1277-1285. 2009
  • Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan..  25:853-860. 2009
  • Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression..  25:555-561. 2009
  • Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115..  25:135-139. 2009
  • Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid..  25:207-212. 2009
  • Analysis of the immune responses in chimpanzees infected with HIV type 1 isolates..  24:573-586. 2008
  • HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021. 2022
  • Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition. 2014
  • Association of HIV-1 Env Antibody Responses with Postnatal Mother-to-Child Transmission of HIV-1 via Breastfeeding. 2014
  • DNA and Protein Co-immunization Improves the Magnitude, Longevity, and Mucosal Dissemination of Immune Responses. 2014
  • Induction of Antibodies with Long Variable Heavy Third Complementarity Determining Regions by Repetitive Boosting with AIDSVAX® B/E in RV144 Vaccinees. 2014
  • Modulation of RAS Pathways as a Biomarker of Protection against HIV and as a Means to Improve Vaccine Efficacy. 2014
  • Role of Intestinal Microbiota in Shaping the B Cell Repertoire in HIV Infection and Env Vaccination. 2014